Shares of drug developer SCI Pharmtech Inc (SCI, 旭富製藥) yesterday plunged by their daily limit to NT$112 after a fire broke out on Sunday at the company’s plant in Taoyuan’s Lujhu District (蘆竹), killing a Filipino worker and causing about NT$800 million (US$28.05 million) in losses.
The fire began at about noon when the production lines were processing chemical solutions, the Taoyuan-based company said.
Because of the chemicals stored in the plant and strong winds, sporadic explosions occurred and the blaze soon spread to the factories of four other companies.
Taoyuan firefighters said they expect to bring the fire under control this afternoon.
SCI Pharmtech spokesman Deiter Yang (楊文禎) told a news conference yesterday that a Filipino worker died early yesterday after being treated for third-degree burns covering 90 percent of his body.
Another employee, a Taiwanese man, was discharged from hospital after being treated for burns to his hand, Yang said.
The company estimated about NT$800 million in losses because of damage to its plant, but added that it should be able to obtain full compensation from insurance companies.
Still, it would take at least six months to rebuild the plant, as most production lines were damaged by the fire, it said.
It estimated another NT$600 million in lost orders in the first quarter, Yang said.
The company has about NT$250 million in finished products, but it needs to assess their quality after the fire, he added.
The Lujhu plant employs about 270 workers, who will all be paid in full up to the Lunar New Year holiday in February, Yang said.
As production has been suspended, the company would evaluate whether it needs to adopt furlough programs, he said.
The fire also damaged the factories of Tao Yuan Paper Manufacturing Co (桃園紙廠), Tung Yang Machine Industry Co (東陽精機), Gwo Chern Industrial Co (國晟工業) and Hong Li International Knitting Co (鴻利國際針織).
SCI Pharmtech is waiting for damage reports from the four before it could determine compensation, Yang said.
The company has NT$30 million in public liability insurance claims for damage to nearby factories, he added.
A subsidiary of local conglomerate Mercuries & Associates Ltd (三商行) and led by chairman Wong Wei-chyun (翁維駿), SCI Pharmtech produces active pharmaceutical ingredients (APIs), cannabidiol intermediates and specialty chemicals.
The company reported cumulative revenue of NT$2.61 billion in the first 11 months of this year, up 18.19 percent from NT$2.21 billion in the same period last year, thanks to steady shipments of APIs for hydroxychloroquine — a medicine used to treat or prevent malaria, lupus and rheumatoid arthritis, as well as mild cases of COVID-19 — and stable sales of other APIs used in drugs for treating epilepsy and depression.
Net profit in the first three quarters of this year was NT$638.92 million, compared with NT$481.6 million in the same period last year, or earnings per share of NT$8.04, compared with NT$6.06 a year earlier, company data showed.
As of yesterday, the company’s shares had risen 2.75 percent this year, underperforming the main bourse, which rose 19.9 percent, Taiwan Stock Exchange data showed.
NOVEMBER ELECTIONS: The KMT urged the CECC to exclude Taiwanese from the arrivals cap, as they would lose their right to vote if they could not return by July 26 The COVID-19-related border control measures and the cap on the number of international arrivals are not being eased, the Central Epidemic Command Center (CECC) said yesterday as it reported 112 imported cases of the Omicron subvariants BA.4 and BA.5 of SARS-CoV-2. Centers for Disease Control (CDC) Deputy Director-General Chuang Jen-hsiang (莊人祥), who is CECC spokesperson, said a meeting was held yesterday morning in which the Cabinet decided that current border control measures would remain in place. He said the main considerations were global COVID-19 cases increasing 21 percent last week, imported cases of Omicron subvariants BA.4 and BA.5 continuing to be detected
TIMING: 'The CHIPS Act funding is crucial for us. In other words, if the act’s passage is delayed for too long, we will certainly need to adjust,’ chairwoman Doris Hsu said GlobalWafers Co (環球晶圓) plans to start construction on a US$5 billion wafer fabrication facility in Texas in November, after passage of the US$52 billion Creating Helpful Incentives to Produce Semiconductors (CHIPS) for America Act. The fab would be the largest of its kind in the US and one of the largest in the world, with a monthly capacity of 1.2 million wafers, GlobalWafers said, adding that the investment would be the first new fab in the US in more than 20 years and critical to closing a semiconductor supply chain gap. The world’s No. 3 silicon wafer supplier said the project, which
Samsung Electronics Co yesterday commenced mass production of 3-nanometer chips that are more powerful and efficient than predecessors, beating rival Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to a key milestone in the race to build the most advanced chips in the world. South Korea’s largest company said in a statement that it was beginning with 3-nanometer semiconductors for high-performance and specialized low-power computing applications before expanding to mobile processors. By applying so-called Gate-All-Around transistor architecture, Samsung’s 3-nanometer products reduce power consumption by up to 45 percent and improve performance by 23 percent compared with 5-nanometer chips, it said. Samsung’s push to be first
Three to four tropical storms or typhoons are expected to hit Taiwan this year due to a weak La Nina effect in the northwest Pacific Ocean, the Central Weather Bureau (CWB) said yesterday, as typhoon season begins next month. Taiwan’s typhoon season generally lasts from July to September, with most typhoons occurring in August. Weather Forecast Center Director Lu Kuo-chen (呂國臣) told a news conference that a weakening La Nina is expected to have less of an effect on Taiwan. “The climate simulation we conducted, and those conducted by other meteorological agencies around the world, showed that the number of typhoons that